nafamostat has been researched along with Chronic Disease in 8 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 65-year-old man with chronic aortic dissection experienced two massive subcutaneous hemorrhages." | 5.35 | Effects of nafamostat mesilate on coagulopathy with chronic aortic dissection. ( Hiraiwa, T; Ito, H; Tanaka, K; Yamamoto, K, 2009) |
| "A 65-year-old man with chronic aortic dissection experienced two massive subcutaneous hemorrhages." | 1.35 | Effects of nafamostat mesilate on coagulopathy with chronic aortic dissection. ( Hiraiwa, T; Ito, H; Tanaka, K; Yamamoto, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsujii, K | 1 |
| Andoh, T | 1 |
| Ui, H | 1 |
| Lee, JB | 1 |
| Kuraishi, Y | 1 |
| Yamamoto, K | 1 |
| Ito, H | 1 |
| Hiraiwa, T | 1 |
| Tanaka, K | 1 |
| Takahagi, S | 1 |
| Shindo, H | 1 |
| Watanabe, M | 1 |
| Kameyoshi, Y | 1 |
| Hide, M | 1 |
| Inoue, K | 1 |
| Yoshiba, M | 1 |
| Urabe, Y | 1 |
| Ideishi, M | 1 |
| Sasaguri, M | 1 |
| Ikeda, M | 1 |
| Arakawa, K | 1 |
| Tomikawa, S | 1 |
| Ando, Y | 1 |
| Nomura, Y | 1 |
| Bech, Y | 1 |
| Doi, T | 1 |
| Homma, H | 1 |
| Mezawa, S | 1 |
| Kida, M | 1 |
| Kukitsu, T | 1 |
| Miyanishi, K | 1 |
| Murase, K | 1 |
| Takada, K | 1 |
| Iyama, S | 1 |
| Niitsu, Y | 1 |
| Ueda, M | 1 |
| Deguchi, M | 1 |
| Takemura, S | 1 |
| Kasamatsu, Y | 1 |
| Yanagida, K | 1 |
| Fukuda, W | 1 |
| Okamoto, M | 1 |
| Onodera, H | 1 |
| Sugino, S | 1 |
| Kondo, M | 1 |
1 review available for nafamostat and Chronic Disease
| Article | Year |
|---|---|
[Blood purification for patients with chronic renal failure accompanied by severe liver disease].
Topics: Acute Disease; Anticoagulants; Benzamidines; Carrier State; Cellulose; Chronic Disease; Dialysis Sol | 2004 |
2 trials available for nafamostat and Chronic Disease
| Article | Year |
|---|---|
Beneficial effects of a serine protease inhibitor in peripheral vascular disease.
Topics: Aged; Arteriosclerosis Obliterans; Benzamidines; Chronic Disease; Exercise Test; Female; Femoral Vei | 1993 |
Leukocytopheresis therapy for chronic renal allograft rejection.
Topics: Adult; Anticoagulants; Antigens, CD; Benzamidines; Chronic Disease; Creatinine; Female; Graft Reject | 2000 |
5 other studies available for nafamostat and Chronic Disease
| Article | Year |
|---|---|
Involvement of Tryptase and Proteinase-Activated Receptor-2 in Spontaneous Itch-Associated Response in Mice With Atopy-like Dermatitis.
Topics: Animals; Benzamidines; Chronic Disease; Dermatitis, Atopic; Disease Models, Animal; Dose-Response Re | 2009 |
Effects of nafamostat mesilate on coagulopathy with chronic aortic dissection.
Topics: Aged; Aortic Aneurysm, Thoracic; Aortic Dissection; Benzamidines; Blood Vessel Prosthesis Implantati | 2009 |
Refractory chronic urticaria treated effectively with the protease inhibitors, nafamostat mesilate and camostat mesilate.
Topics: Adult; Benzamidines; Chronic Disease; Drug Therapy, Combination; Esters; Female; Gabexate; Guanidine | 2010 |
[A case of pancreatic ascites due to rupture of pancreatic pseudocyst successfully treated with continuous arterial infusion of nafamostat mesilate].
Topics: Aged; Ascitic Fluid; Benzamidines; Chronic Disease; Guanidines; Humans; Infusions, Intra-Arterial; M | 2001 |
[The relationship between complement C3 receptors (CR1, CR3) on polymorphonuclear leukocytes and complement fragments during hemodialysis].
Topics: Aged; Aged, 80 and over; Benzamidines; Cells, Cultured; Chronic Disease; Complement C3; Complement C | 1991 |